Table 3 Adverse events occurring in at least 10% of patients in either treatment group.
Adverse event | Sugammadex (n = 46) | Neostigmine (n = 36) |
|---|---|---|
Procedural pain | 33 (71.7) | 24 (66.7) |
Nausea | 24 (52.2) | 12 (33.3) |
Incision-site complication | 10 (21.7) | 8 (22.2) |
Pharyngolaryngeal pain | 8 (17.4) | 7 (19.4) |
Headache | 12 (26.1) | 2 (5.6) |
Vomiting | 9 (19.6) | 4 (11.1) |
Dizziness | 5 (10.9) | 4 (11.1) |
Pruritus | 5 (10.9) | 2 (5.6) |
Post-procedural nausea | 5 (10.9) | 2 (5.6) |
Constipation | 5 (10.9) | 0 |
Chills | 5 (10.9) | 0 |